Navigation Links
22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Date:10/5/2010

This Symposium, organised jointly by the European Organisation for the Research and Treatment of Cancer, the US National Cancer Institute and the American Association for Cancer Research, offers the media:

  • Cutting edge information on new cancer drug research and development from experts in Europe, North America, Asia and Australia;
  • Free registration for bona fide media with official press credentials (press card and/or a commissioning letter on headed paper from the editor of the journal/website they represent);
  • All sessions open to journalists;
  • Media centre with free computing, international phones, and internet.

Around 2,200 international experts in cancer research will present and discuss recent advances in the early development of promising new compounds in different stages of pre-clinical and clinical research.

We welcome the media to the Symposium. Copies of the credentials and identification will be requested at the time of registration and when journalists arrive at the Symposium. Business cards are NOT acceptable.

NB: the official language of the symposium is English and all press materials will be in English.

For media registration, a media registration form can be downloaded at: http://www.ecco-org.eu/Conferences-and-Events/EORTC-NCI-AACR-2010/News-Media-and-Public-Relations-Policy/page.aspx/2406

Please email it to: Riitta.Kettunen@ecco-org.eu
Tel: +32 2 775 02 05
Fax: +32 2 775 02 00

More information on the programme and hotel accommodation is available on the EORTC-NCI-AACR symposium website at: http://www.ecco-org.eu/

Accommodation:

The Estrel Hotel is the official hotel for EORTC-NCI-AACR 2010.

You are encouraged to book on-line via the Symposium website: www.ecco-org.eu or complete the hotel reservation form found in the Symposium programme at www.ecco-org.eu and return it by fax, email or post to the following address:

Estrel Hotel and Convention Centre
Sonnenallee 225
12057 Berlin - Germany
Tel: +49 (0)30 6831 0
Fax: +49 (0)30 6831 2345
E-mail: reservation@estrel.com

Reservations are made on a first-come, first-served basis and participants are advised to book early.


'/>"/>

Contact: Emma Mason
wordmason@mac.om
ECCO-the European CanCer Organisation
Source:Eurekalert

Related biology news :

1. Stem Cells and International Stem Cell Symposium present annual stem cells award
2. Military medicine symposium to explore regenerative medicine, behavioral health
3. Sutherland and Berglass to keynote USU-HJF Military Medicine Symposium
4. University at Buffalo symposium on in silico methods, high throughput screening
5. American Chemical Society, Council for Chemical Research to hold R&D symposium Aug. 22
6. Ecologists to discuss impacts of mountaintop mining at special ESA symposium
7. Symposium to explore broadening partnerships to spur medical advances for war injuries
8. American Chemical Society symposium on Deepwater Horizon oil spill on Aug. 24
9. Flowers do it, trees do it: Symposium on plant reproduction
10. IRSF lauds record turn-out for annual Rett Syndrome Symposium
11. Announcing the 1st IOF-ESCEO Pre-Clinical Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2016)...  As part of its longstanding mission to improve genetic ... recently released its latest children,s book, titled The ... the topics of inheritance and variation of traits that are ... elementary school classrooms in the US. The ... Ariana Killoran , whose previous book with 23andMe, ...
(Date:12/20/2016)... The rising popularity of mobility services ... stoking significant interest in keyless access systems. Following ... energy (BLE), biometrics and near-field communication (NFC) are ... wireless technologies in the automotive industry. This evolution ... systems opens the market to specialist companies such ...
(Date:12/19/2016)... y TORONTO , 19 de diciembre de 2016 ... Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado ... tipos de tumor en 2017, con múltiples sitios previstos a lo ... ... objetivo en el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica ...
Breaking Biology News(10 mins):
(Date:1/16/2017)... MANHASSET, N.Y. , Jan. 16, 2017   ... Kevin J. Tracey, MD , president and CEO of ... Northwell Health, completed an analysis of how the nervous ... further identify and develop bioelectronic medicine devices ... today in Nature Neuroscience . The ...
(Date:1/16/2017)... , Jan. 16, 2017  Eurofins Genomics today ... will allow more customers to receive their primers in ... or compromise in quality found with other providers. Express ... United States at no additional fee. ... routine genetic studies, including DNA sequencing, genotyping, site-directed mutagenesis, ...
(Date:1/14/2017)... , Jan. 13, 2017  The Alliance for Safe ... response to FDA final guidance on biologic ... continued leadership in emphasizing the importance of distinct naming ... aware of the benefits biosimilars will bring to patients, ... Yet the portion of the Guidance dealing with ...
(Date:1/13/2017)... , Jan 13, 2017 Research and Markets has ... to their offering. ... global biopolymers market to grow at a CAGR of 16.83% during the ... the growth prospects of the global biopolymers market for 2017-2021. To calculate ... of sales of biopolymer products. The report also includes a a discussion ...
Breaking Biology Technology: